It’s cool, it’s a nice study. The article definitely over hypes the “common cause of hypertension”. These lesions are rare. Most people with high blood pressure have it because of metabolic disease/chronic stress/lifestyle, and it can be managed with changes to diet exercise and meds.
It is true that doing adrenal vein sampling is hard and not always successful. Having a protocol that can non-invasively detect these lesions may save some people a procedure.
Do we know this though? If, as the article claims, the lesions were previously hard to detect, I would guess that most people with them never get diagnosed. I have high blood pressure and I've never been examined for those lesions.
Edited for clarity
- ~50% of adult Americans have hypertension
- scanning all medication-non-responders (= people suffering from "resistant hypertension") and operating on all of them to remove the causative nodules sounds like quite the tall order
- doctors won't just suddenly start sending all the resistant hypertension patients to CTs to diagnose this cause, instead they will continue to escalate their patients anti-hypertensive medication, i.e. adding an aldosterone antagonist to the three other maximum dosage blood pressure lowering medications the patient already takes.
- this might become an option for people suffering from resistant hypertension that are receiving expensive, excellent state of the art treatment
AVS is correlated using a non-metomidate adrenal CT scan anyway, so a CT-only option would be less expensive and could be performed in more facilities, making it more accessible:
> Until now, 99% are never diagnosed because of the difficulty and unavailability of tests.
And since AVS has such a low predictive success rate (63% per the study), the CT-scan-only alternative doesn't even have to be good, it just has to be about as bad as AVS.
The results of either could very well be "keep taking meds for 40 years" or "surgery helps immensely", but the real cost savings are in avoiding AVS and also potentially diagnosing and treating more people sooner.
(Also mind that the study's done in the UK, where CT scans cost patients about £800/US$1,000 even when done privately, and in Scotland/Wales/N. Ireland the meds are free to the patient. In the US, a CT scan averages about $5,000, $12,000 isn't unheard of, and the meds cost $7,000-$20,000 for 40 years.)
Many of those patients will continue to have high blood pressure for other reasons (obesity, fat intake, renal impairment, god knows what else) and will need to continue their medication, maybe they will downgrade (upgrade? (-; ) from treatment resistant hypertension to normal hypertension. A significant amount of the patients receiving surgery will suffer from mild to severe bacterial infections that also need treatment.
At the top of my head I would still say yes, it would be cheaper.
ALSO and BUT: Please do not expect a treatment that is both cheaper and better for the quality of life of the patient to be chosen by default. Hospitals and doctors don't work that way.
When I go through my insurance with their preferred pharmacy, I don't pay anything. But according to CVS my insurance company pays $1.87 for 90 pills, so about $7/year
https://costplusdrugs.com/medications/lisinopril-2_5mg-table...
I like to minimize on my needed medications though. I would probably opt for this if it were available.
I understand something similar is done for Morbus Basedow / Grave's disease with the thyroid gland.
You are probably referencing "radioiodine therapy" which is highly specific to thyroid issues.
Integrating new techniques like this into commonly available treatment is HARD.